Tamila Kindwall-Keller, DO

Tamila Kindwall-Keller, DO

Research Description

I am an assistant Professor of Medicine at the University of Virginia and the Associate Clinical Director of the Hematopoietic Stem Cell Transplant Program. My research interests include the clinical application of stem cell transplant for the treatment of hematologic malignancies and developing new therapeutic drugs for the treatment of multiple myeloma for both before and after stem cell transplantation. I have worked over the past 5 years to develop stem cell transplant and multiple myeloma investigator initiated trials. I have had extensive prior experience in being the principal investigator and directing both investigator-initiated, cooperative group, and pharmaceutical trials in stem cell transplant and multiple myeloma. Additionally, I have been the medical monitor for several national cooperative group stem cell transplant trials.

Biographical Statement

Dr. Kindwall-Keller is an Assistant Professor of Medicine and Associate Clinical Director of Stem Cell Transplantation at UVA. Clinical responsibilities include the treatment of multiple myeloma and stem cell transplant. Her research interests include the clinical application of stem cell transplant for the treatment of hematologic malignancies and developing new therapeutic drugs for the treatment of multiple myeloma for both before and after stem cell transplantation. She has had extensive prior experience in being the principal investigator and directing both investigator-initiated, cooperative group, and pharmaceutical trials in stem cell transplant and hematologic malignancies. She has prior training and experience in the design and implementation of human clinical trials. Additionally, she has been the medical monitor for several national cooperative group stem cell transplant trials. Dr. Kindwall-Keller has completed a Master’s Degree in Clinical Research through UVA in 2013. She is the medical director of stem cell cytotherapy laboratory and co-quality liaison for hematology/oncology division. Dr. Kindwall-Keller participates in the data safety monitoring committee and the protocol review committee at UVA. Nationally, she is a medical monitor for Blood and Marrow Transplant Clinical Trials Network. Prior to coming to the University of Virginia in 2011 she was an Assistant Professor at University Hospitals of Cleveland, Case Medical Center.